• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.54% Nasdaq Down 0.61%

    Delcath Systems, Inc. (DCTH)

    -NasdaqCM
    0.33 Up 0.01(2.75%) 10:44AM EDT - Nasdaq Real Time Price
    Prev Close:0.32
    Open:0.33
    Bid:0.32 x 100
    Ask:0.34 x 400
    1y Target Est:1.00
    Beta:1.05077
    Earnings Date:May 4 - May 9 (Est.)
    Day's Range:0.33 - 0.34
    52wk Range:0.25 - 1.92
    Volume:5,388
    Avg Vol (3m):149,702
    Market Cap:7.91M
    P/E (ttm):N/A
    EPS (ttm):-0.96
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for DCTH

    Comparison

    Symbol% ChgMkt Cap
    DCTHUp 2.75%7.91M
    LLYDown 0.85%80.00B
    PFEDown 0.50%202.75B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.36
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.12
    Quarterly EPS Est (Mar-16) :-0.19
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.02

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback